Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kush Arvind Insider Profile
4 Followers
Kush Arvind, CFO at RayzeBio, Inc., holds 145.00K shares in Inhibikase Therapeutics (Ticker: IKT), holds 0.00 shares in RayzeBio, Inc. (Ticker: RYZB). Most recently, Kush Arvind Bought ― shares of Inhibikase Therapeutics on Oct 23, 2024 for an estimated value of 198.65K.
Kush Arvind RayzeBio, Inc. (RYZB)CFO
RayzeBio, Inc. (RYZB)
CFO
Not Ranked
Kush Arvind has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Kush Arvind holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kush Arvind
Kush Arvind's Trading History
RayzeBio, Inc.
Feb 27, 2024
―
Uninformative Sell
4.90M
$0.00
Inhibikase Therapeutics
Oct 23, 2024
Director
Informative Buy
198.65K
$464.00K
List of latest transactions for each holding click on a transaction to see Kush Arvind's performance on stock
You May Also Like
Kush Arvind insider profile FAQ
What is the percentage of profitable transactions made by Kush Arvind?
The percentage of profitable transactions made by Kush Arvind is ―.
What is the average return per transaction made by Kush Arvind?
The average return per transaction made by Kush Arvind is ―.
What stocks does Kush Arvind hold?
Kush Arvind holds: RYZB, IKT stocks.
What was Kush Arvind’s latest transaction?
Kush Arvind latest transaction was an Informative Buy of $198.65K.
What was Kush Arvind's most profitable transaction?
Kush Arvind’s most profitable transaction was an Informative Buy of IKT stock on October 23, 2024. The return on the trade was 31.60%.
What is Kush Arvind's role in RayzeBio, Inc.?
Kush Arvind's role in RayzeBio, Inc. is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.